Engineering for Cancer Therapies
-
A novel treatment for leukemias and lymphomas that arise from immune system T cells, developed by investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center and Lustgarten Laboratory, was found… Read More
-
Joshua Doloff, an assistant professor in the Department of Biomedical Engineering and affiliate researcher at the Institute for NanoBioTechnology, has won a three-year, $450,000 grant from Ovarian Cancer Research Alliance to design new drug delivery systems for more precise treatment of… Read More
-
Researchers from Johns Hopkins University and Universidad Carlos III de Madrid have created a computational model that simulates the growth of breast tumors from a biomechanical perspective. Their innovative approach,… Read More
-
Our immune system is like the police force of our body, generally protecting us from harm such as infection or cancer, explains Johns Hopkins rheumatologist Maximilian F. Konig. When we encounter… Read More
-
Story by Johns Hopkins School of Medicine. What Works for Cancer Immunotherapy May Also Work for Alzheimer’s Disease In experiments with lab-grown brain cells and mouse models, scientists at Johns… Read More
-
Story by Lisa Ercolano During January’s World Economic Forum in Davos, Switzerland, experts cautioned that by 2050, as many as 10 million people a year could die from drug-resistant bacteria,… Read More
